DEEP Measures, founded in 2022 and headquartered in Finland, is carving a niche in the digital health sector by bridging the gap between vital healthcare information and key stakeholders. Under the slogan, "Taking digital measures of health to the finish line," the company is focused on developing digital health metrics essential for enhancing clinical trial efficiencies and patient outcomes globally.
The company is not directly linked to any specific industry category, suggesting a broader focus within the health-tech domain. In its short operational span, DEEP Measures has already attracted significant attention, securing a €3.00M seed round investment on 01 May 2023. Reputable investors such as Insight Partners, Nina Ventures, and Innovestor backed this round, indicating strong market interest and confidence in DEEP’s potential.
By aligning themselves with this innovative ecosystem, investors can tap into the transformative potential that digital health measurements promise to unlock in the healthcare landscape.